Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-γ treatment

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 2, 2007, Pages 219-231

  Maubach, Gunter ^a   Lim, Michelle Chin Chia ^a   Kumar, Saravana ^a   Zhuo, Lang ^a  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Cathepsin S; CD74; CIITA; Hepatic stellate cell; Invariant chain; MHC class II

Indexed keywords

ANTIGEN; CATHEPSIN S; CD74 ANTIGEN; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CELL STRAIN; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; INFLAMMATION; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; STELLATE CELL; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION;

ALBUMINS; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; CATHEPSINS; CELL SEPARATION; CELLS, CULTURED; CYSTEINE ENDOPEPTIDASES; FLUORESCENCE; HEPATOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-D ANTIGENS; IMMUNOLOGIC FACTORS; INTERFERON TYPE II; NUCLEAR PROTEINS; RATS; RATS, WISTAR; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UP-REGULATION;

RATTUS;

EID: 33846431997     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2006.11.005     Document Type: Article

References (34)

1. Sato M., Suzuki S., and Senoo H. Hepatic stellate cells: unique characteristics in cell biology and phenotype. Cell Struct. Funct. 28 (2003) 105-112
2. Bataller R., and Brenner D.A. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin. Liver Dis. 21 (2001) 437-451
3. Lotersztajn S., Julien B., Teixeira-Clerc F., Grenard P., and Mallat A. Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 45 (2005) 605-628
4. Viñas O., Bataller R., Sancho-Bru P., Ginès P., Berenguer C., Enrich C., Nicolás J.M., Ercilla G., Gallart T., Vives J., Arroyo V., and Rodés J. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology 38 (2003) 919-929
5. Yu M.C., Chen C.H., Liang X., Wang L., Gandhi C.R., Fung J.J., Lu L., and Qian S. Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology 40 (2004) 1312-1321
6. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340 (1999) 448-454
7. Wigmore S.J., Fearon K.C., Maingay J.P., Lai P.B., and Ross J.A. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am. J. Physiol. 273 (1997) E720-E726
8. Limmer A., Ohl J., Kurts C., Ljunggren H.G., Reiss Y., Groettrup M., Momburg F., Arnold B., and Knolle P.A. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance. Nat. Med. 6 (2000) 1348-1354
9. Shiratori Y., Okano K., Matsumoto K., and Murao S. Antigen presentation by Kupffer cells in the rat. Scand. J. Gastroenterol. 19 (1984) 733-739
10. Roland C.R., Walp L., Stack R.M., and Flye M.W. Outcome of Kupffer cell antigen presentation to a cloned murine Th1 lymphocyte depends on the inducibility of nitric oxide synthase by IFN-gamma. J. Immunol. 153 (1994) 5453-5464
11. O'Connell P.J., Morelli A.E., Logar A.J., and Thomson A.W. Phenotypic and functional characterization of mouse hepatic CD8 alpha+ lymphoid-related dendritic cells. J. Immunol. 165 (2000) 795-803
12. Johansson C., and Wick M.J. Liver dendritic cells present bacterial antigens and produce cytokines upon Salmonella encounter. J. Immunol. 172 (2004) 2496-2503
13. Lau A.H., and Thomson A.W. Dendritic cells and immune regulation in the liver. Gut 52 (2003) 307-314
14. LeibundGut-Landmann S., Waldburger J.M., Krawczyk M., Otten L.A., Suter T., Fontana A., Acha-Orbea H., and Reith W. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34 (2004) 1513-1525
15. Nakagawa T., Roth W., Wong P., Nelson A., Farr A., Deussing J., Villadangos J.A., Ploegh H., Peters C., and Rudensky A.Y. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 280 (1998) 450-453
16. Riese R.J., Mitchell R.N., Villadangos J.A., Shi G.P., Palmer J.T., Karp E.R., De Sanctis G.T., Ploegh H.L., and Chapman H.A. Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 101 (1998) 2351-2363
17. Beers C., Burich A., Kleijmeer M.J., Griffith J.M., Wong P., and Rudensky A.Y. Cathepsin S controls MHC class II-mediated antigen presentation by epithelial cells in vivo. J. Immunol. 174 (2005) 1205-1212
18. Driessen C., Bryant R.A., Lennon-Dumenil A.M., Villadangos J.A., Bryant P.W., Shi G.P., Chapman H.A., and Ploegh H.L. Cathepsin S controls the trafficking and maturation of MHC class II molecules in dendritic cells. J. Cell Biol. 147 (1999) 775-790
19. Riccalton-Banks L., Bhandari R., Fry J., and Shakesheff K.M. A simple method for the simultaneous isolation of stellate cells and hepatocytes from rat liver tissue. Mol. Cell. Biochem. 248 (2003) 97-102
20. Vogel S., Piantedosi R., Frank J., Lalazar A., Rockey D.C., Friedman S.L., and Blaner W.S. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41 (2000) 882-893
21. Steimle V., Siegrist C.A., Mottet A., Lisowska-Grospierre B., and Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265 (1994) 106-109
22. Lennon A.M., Ottone C., Rigaud G., Deaven L.L., Longmire J., Fellous M., Bono R., and Alcaide-Loridan C. Isolation of a B-cell-specific promoter for the human class II transactivator. Immunogenetics 45 (1997) 266-273
23. Flannery T., Gibson D., Mirakhur M., McQuaid S., Greenan C., Trimble A., Walker B., McCormick D., and Johnston P.G. The clinical significance of cathepsin S expression in human astrocytomas. Am. J. Pathol. 163 (2003) 175-182
24. Soos J.M., Krieger J.I., Stuve O., King C.L., Patarroyo J.C., Aldape K., Wosik K., Slavin A.J., Nelson P.A., Antel J.P., and Zamvil S.S. Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN-gamma-inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4(+) T-cell activation. Glia 36 (2001) 391-405
25. Storm van's Gravesande K., Layne M.D., Ye Q., Le L., Baron R.M., Perrella M.A., Santambrogio L., Silverman E.S., and Riese R.J. IFN regulatory factor-1 regulates IFN-gamma-dependent cathepsin S expression. J. Immunol. 168 (2002) 4488-4494
26. Rahat M.A., Chernichovski I., and Lahat N. Increased binding of IFN regulating factor 1 mediates the synergistic induction of CIITA by IFN-γ and tumor necrosis factor-α in human thyroid carcinoma cells. Int. Immunol. 13 (2001) 1423-1432
27. Harton J.A., and Ting J.P. Class II transactivator: mastering the art of major histocompatibility complex expression. Mol. Cell. Biol. 20 (2000) 6185-6194
28. Kindberg G.M., Magnusson S., Berg T., and Smedsrod B. Receptor-mediated endocytosis of ovalbumin by two carbohydrate-specific receptors in rat liver cells. The intracellular transport of ovalbumin to lysosomes is faster in liver endothelial cells than in parenchymal cells. Biochem. J. 270 (1990) 197-203
29. Mousavi S.A., Sato M., Sporstol M., Smedsrod B., Berg T., Kojima N., and Senoo H. Uptake of denatured collagen into hepatic stellate cells: evidence for the involvement of urokinase plasminogen activator receptor-associated protein/Endo180. Biochem. J. 387 (2005) 39-46
30. Villadangos J.A. Presentation of antigens by MHC class II molecules: getting the most out of them. Mol. Immunol. 38 (2001) 329-346
31. Xu Y., Wang L., Buttice G., Sengupta P.K., and Smith B.D. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon gamma (IFN-gamma). J. Biol. Chem. 279 (2004) 41319-41332
32. Yang H., Kala M., Scott B.G., Goluszko E., Chapman H.A., and Christadoss P. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis. J. Immunol. 174 (2005) 1729-1737
33. Shi G.P., Sukhova G.K., Kuzuya M., Ye Q., Du J., Zhang Y., Pan J.H., Lu M.L., Cheng X.W., Iguchi A., Perrey S., Lee A.M.E., Chapman H.A., and Libby P. Deficiency of the cysteine protease cathepsin S impairs microvessel growth. Circ. Res. 92 (2003) 493-500
34. Wang B., Sun J., Kitamoto S., Yang M., Grubb A., Chapman H.A., Kalluri R., and Shi G.P. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J. Biol. Chem. 281 (2006) 6020-6029